Third Rock keeps its options open
Why Third Rock likes multi-asset option deals for its newcos
Third Rock Ventures is cementing its strategy to create newcos that can succeed as stand-alone companies. The VC has ditched the build-to-buy model in favor of one that gives a pharma broad options to multiple programs.
The idea is to bring in a pharma early on, and give it options to multiple products from the biotech’s platform, rather than the entire biotech. ...